Skip to content

Research at St Andrews

Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial

Research output: Contribution to journalArticlepeer-review


Augusto Azuara-Blanco, Jennifer Burr, Craig Ramsay, David Cooper, Paul J. Foster, David S. Friedman, Graham Scotland, Mehdi Javanbakht, Claire Cochrane, John Norrie, EAGLE study group

School/Research organisations


Background. Primary angle-closure glaucoma is a leading cause of irreversible blindness worldwide. In early-stage disease, intraocular pressure is raised without visual loss. Because the crystalline lens has a major mechanistic role, lens extraction might be a useful initial treatment.
Methods. From Jan 8, 2009, to Dec 28, 2011, we enrolled patients from 30 hospital eye services in five countries. Randomisation was done by a web-based application. Patients were assigned to undergo clear-lens extraction or receive standard care with laser peripheral iridotomy and topical medical treatment. Eligible patients were aged 50 years or older, did not have cataracts, and had newly diagnosed primary angle closure with intraocular pressure 30 mm Hg or greater or primary angle-closure glaucoma. The co-primary endpoints were patient-reported health status, intraocular pressure, and incremental cost-effectiveness ratio per quality-adjusted life-year gained 36 months after treatment. Analysis was by intention to treat. This study is registered, number ISRCTN44464607.
Findings. Of 419 participants enrolled, 155 had primary angle closure and 263 primary angle-closure glaucoma. 208 were assigned to clear-lens extraction and 211 to standard care, of whom 351 (84%) had complete data on health status and 366 (87%) on intraocular pressure. The mean health status score (0·87 [SD 0·12]), assessed with the European Quality of Life-5 Dimensions questionnaire, was 0·052 higher (95% CI 0·015–0·088, p=0·005) and mean intraocular pressure (16·6 [SD 3·5] mm Hg) 1·18 mm Hg lower (95% CI –1·99 to –0·38, p=0·004) after clear-lens extraction than after standard care. The incremental cost-effectiveness ratio was £14 284 for initial lens extraction versus standard care. Irreversible loss of vision occurred in one participant who underwent clear-lens extraction and three who received standard care. No patients had serious adverse events.
Interpretation. Clear-lens extraction showed greater efficacy and was more cost-effective than laser peripheral iridotomy, and should be considered as an option for first-line treatment.


Original languageEnglish
Pages (from-to)1389-1397
Number of pages9
Issue number10052
Early online date29 Sep 2016
Publication statusPublished - 1 Oct 2016

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author


    Keralink Trial Study Group, 20 Apr 2021, In: Ophthalmology.

    Research output: Contribution to journalArticlepeer-review

  2. Trends in diabetic retinopathy screening attendance and associations with vision impairment attributable to diabetes in a large nationwide cohort

    Lawrenson, J. G., Bourmpaki, E., Bunce, C., Stratton, I. M., Gardner, P., Anderson, J. & EROS Study Group, Apr 2021, In: Diabetic Medicine. 38, 4, 11 p., e14425.

    Research output: Contribution to journalArticlepeer-review

  3. Femtosecond laser-assisted cataract surgery compared with phacoemulsification: the FACT non-inferiority RCT

    Day, A. C., Burr, J. M., Bennett, K., Hunter, R., Bunce, C., Doré, C. J., Nanavaty, M. A., Balaggan, K. S. & Wilkins, M. R., 1 Jan 2021, In: Health Technology Assessment. 25, 6, p. 1-68 68 p.

    Research output: Contribution to journalArticlepeer-review

  4. Femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery (FACT): a randomized noninferiority trial

    Day, A. C., Burr, J. M., Bennett, K., Bunce, C., Doré, C. J., Rubin, G. S., Nanavaty, M. A., Balaggan, K. S., Wilkins, M. R. & FACT trial group, Aug 2020, In: Ophthalmology. 127, 8, p. 1012-1019 8 p.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

    Vasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., Bedston, S., Beggs, J., Bradley, D., Chuter, A., de Lusignan, S., Docherty, A. B., Ford, D., Hobbs, FD. R., Joy, M., Katikireddi, S. V., Marple, J., McCowan, C., McGagh, D., McMenamin, J. & 12 others, Moore, E., Murray, J. LK., Pan, J., Ritchie, L., Shah, S. A., Stock, S., Torabi, F., Tsang, R. SM., Wood, R., Woolhouse, M., Robertson, C. & Sheikh, A., 23 Apr 2021, In: The Lancet. In press

    Research output: Contribution to journalArticlepeer-review

  2. School reopening without robust COVID-19 mitigation risks accelerating the pandemic

    Gurdasani, D., Alwan, N. A., Greenhalgh, T., Hyde, Z., Johnson, L., McKee, M., Michie, S., Prather, K. A., Rasmussen, S. D., Reicher, S., Roderick, P. & Ziauddeen, H., 27 Mar 2021, In: The Lancet. 397, 10280, p. 1177-1178 2 p.

    Research output: Contribution to journalLetter

  3. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3

    Global Burden of Disease Health Financing Collaborator Network & Cevik, M., 23 Apr 2020, In: Lancet. Online First, 32 p.

    Research output: Contribution to journalArticlepeer-review

  4. The COVID-19 vaccines rush: participatory community engagement matters more than ever

    Burgess, R. A., Osborne, R. H., Yongabi, K. A., Greenhalgh, T., Gurdasani, D., Kang, G., Falade, A. G., Odone, A., Busse, R., Martin-Moreno, J. M., Reicher, S. & McKee, M., 10 Dec 2020, In: The Lancet. In Press

    Research output: Contribution to journalComment/debatepeer-review

  5. The UK needs a sustainable strategy for COVID-19

    Gurdasani, D., Bear, L., Bogaert, D., Burgess, R. A., Busse, R., Cacciola, R., Charpak, Y., Colbourn, T., Drury, J., Friston, K., Gallo, V., Goldman, L. R., Greenhalgh, T., Hyde, Z., Kuppalli, K., Majumder, M. S., Martin-Moreno, J. M., McKee, M., Michie, S., Mossialos, E. & 16 others, Nouri, A., Pagel, C., Pimenta, D., Popescu, S., Priesemann, V., Rasmussen, A. L., Reicher, S., Ricciardi, W., Rice, K., Silver, J., Smith, T. C., Wenham, C., West, R., Yamey, G., Yates, C. & Ziauddeen, H., 9 Nov 2020, In: The Lancet. In Press, 2 p.

    Research output: Contribution to journalComment/debate

ID: 246389135